Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Acadia, Adaptive, Allovir, Amneal, Aqualung, Arrowhead, Biontech, Cannabics, Cellenkos, Celltex, Cel-Sci, Codexis, Cytocom, Eli Lilly, Entos, E-therapeutics, Fujifilm, Fujitsu, Generex, Geovax Labs, Ibio, Immix, Immune, Junshi, Mannkind, Moleculin, Montreal Heart Institute, Nascent, Neoimmunetech, Neuren, Novan, Olix, Pfizer, Pharnext, Pluristem, Polarisqb, Regeneron, Resverlogix, Revive, Ribomic, Roche, Roivant, Signpath, Smartpharm, Soligenix, Sorrento, Sosei, Stabilitech, Takeda, Tarveda, Ubix, Vaxart, Vaxxas, WPD, Ziphius.

Biopharmas in Asia-Pacific raising money in public or private financings, including: IMV, Lattice Biologics, Tiziana Life Sciences.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Epimab Biotherapeutics, I-Mab Biopharma, Sumitomo Dainippon Pharma.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aegea Medical, Biolase, Biofire Defence, Biomérieux, Diacarta, Helius Medical Technologies, Mesa Biotech.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3M, Affinity Health Partners, Allogene Therapeutics, Bellaseno, Curemetrix, Decipher Biosciences, Fiat Chrysler Automobiles, Ford Motor, GE Healthcare, Genmark Diagnostics, Global Center for Medical Innovation, Heat Biologics, Intervenn Biosciences, Iqvia, Letsgetchecked, Maxcyte, Nano-X Imaging, No Borders, Nuclein, Pathsensors, Protex, Q2 Solutions, Qiagen, Quest Diagnostics, Tamarin Health, Vero Biotech, Zoll.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Radlogics.

Med-tech firms raising money in public or private financings, including: Thermo Fisher Scientific.

New hires and promotions in the med-tech industry, including: Myriad Genetics, Qiagen, Scipher Medicine.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Chipscreen, Gilead, Inmed, Prevail, Samsung Bioepis.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ability, Acura, Akers, Aldeyra, Algernon, Ampio, Atyr, Axim, Bioinvent, Cystron, Inovio, Ivix, Lonza, Mabpharm, Ology, Ovoca, Pieris, Point, Protokinetix, Resverlogix, Roche, Santhera, Skylindex, Sorrento, Servier, Triumvira, Valneva, Vero, Windtree.